D-Penicillamin Add-On Therapy Compared to Risperidone Alone in Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial

Phase 4

• Conditions: Schizophrenia.; Schizophrenia

• Registration Number: IRCT138801241457N4
• Lead Sponsor: Mazandaran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

diagnosis of schizophrenia according to DSM-IV-TR with two physicians
Exclusion criteria: hepatic failure, renal failure, malignancies, pregnancy, drug addiction

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Severity of symptoms. Timepoint: weekly. Method of measurement: PANSS.

Secondary Outcome Measures

Name	Time	Method
Faster response to risperidone and side effects. Timepoint: weekly. Method of measurement: PANSS, Liver Function Laboratory Tests, and checklist.